Stock market week-in-review for 5 large GI companies — Sept. 11-15

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Sept. 11 to Sept 15, 2017.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $236.08 on Sept. 11
Peaked at open
Closed: $ 220.07 on Sept. 15
Percent change between Sept. 11 and Sept. 15: -6.78 percent

2. Exact Sciences Corp.

Opened: $43.39 on Sept. 11
Peaked at open
Closed: $42.80 on Sept. 15
Percent change between Sept. 11 and Sept. 15: -1.35 percent

3. Johnson & Johnson

Opened: $131.34 on Sept. 11
Peaked: $125.19 on Sept. 15
Closed: $134.54 on Sept. 15
Percent change between Sept. 11 and Sept. 15: 2.43 percent

4. Synergy Pharmaceuticals

Opened: $2.80 on Sept. 11
Peaked: $2.89 on Sept. 12
Closed: $2.70 on Sept. 15
Percent change between Sept. 11 and Sept. 15: -3.47 percent

5. Valeant Pharmaceuticals

Opened: $14 on Sept. 11
Peaked: $14.60 on Sept. 12
Closed: $13.90 on Sept. 15
Percent change between Sept. 11 and Sept. 15: -0.71 percent

More articles on gastroenterology: 
How Exact Sciences’ Cologuard has a higher compliance rate than traditional CRC screening method
GI leader to know: Dr. Timothy Halterman of Gastroenterology Consultants
National Institute of Environmental Health Sciences awards Dr. Matthew Cave $4.01M grant — 5 key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.